AMRX - Amneal gets FDA approval for potassium phosphate IV bags
2024-07-29 17:07:57 ET
More on Amneal Pharmaceuticals
- Amneal Pharmaceuticals: Maintaining Momentum Is Key To Success
- Amneal Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
- Amneal Pharmaceuticals, Inc. (AMRX) Q1 2024 Earnings Call Transcript
- Amneal stock climbs on Q1 report, opioid settlement update
- Amneal Pharmaceuticals Non-GAAP EPS of $0.14 beats by $0.05, revenue of $659M beats by $39.97M